|
|
Volumn 39, Issue 10, 2001, Pages 73-75
|
|
Atovaquone + proguanil for malaria prophylaxis
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIPARASITIC AGENT;
ATOVAQUONE PLUS PROGUANIL;
CHLOROQUINE;
DOXYCYCLINE;
MEFLOQUINE;
PLACEBO;
PROGUANIL;
RIFABUTIN;
RIFAMPICIN;
ANTIMALARIAL AGENT;
ATOVAQUONE;
NAPHTHOQUINONE;
ACUTE DISEASE;
ADOLESCENT;
ADULT;
ANTIMICROBIAL ACTIVITY;
ARTICLE;
BREAST FEEDING;
CHILD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG ABSORPTION;
DRUG CONTRAINDICATION;
DRUG COST;
DRUG EFFICACY;
DRUG EXCRETION;
DRUG HALF LIFE;
DRUG MANUFACTURE;
ENDEMIC DISEASE;
GASTROINTESTINAL SYMPTOM;
HUMAN;
IMMUNITY;
KIDNEY DISEASE;
LICENCE;
MALARIA CONTROL;
MALARIA FALCIPARUM;
OUTCOMES RESEARCH;
PLASMODIUM FALCIPARUM;
RANDOMIZED CONTROLLED TRIAL;
SIDE EFFECT;
TRAVEL;
UNITED KINGDOM;
DRUG ADMINISTRATION;
DRUG COMBINATION;
REVIEW;
ANTIMALARIALS;
ATOVAQUONE;
CHLOROGUANIDE;
DRUG ADMINISTRATION SCHEDULE;
DRUG COMBINATIONS;
ENDEMIC DISEASES;
HUMANS;
MALARIA, FALCIPARUM;
NAPHTHOQUINONES;
TRAVEL;
|
|
EID: 0034750971
PISSN: 00126543
EISSN: None
Source Type: Journal
DOI: 10.1136/dtb.2001.391073 Document Type: Article |
|
Times cited : (4)
|
|
References (14)
|
